Key points
- A coenzyme required by every cell for energy metabolism and redox reactions
- Tissue levels decline measurably with age across multiple species
- Acts as an obligatory substrate for sirtuins and PARP enzymes, linking it to DNA repair
- Whether restoring levels reverses functional decline remains the open question
Why NAD+ occupies such a central position
Nicotinamide adenine dinucleotide is not a signalling peptide or a hormone — it is a coenzyme, and one that essentially every cell requires. It cycles between oxidised (NAD+) and reduced (NADH) forms, and that cycling is what makes glycolysis, the citric acid cycle and oxidative phosphorylation possible.
This is why it attracts attention in aging research. A molecule sitting at the centre of energy metabolism, whose availability declines with age, is a natural candidate for explaining why cellular function degrades over time.
The sirtuin connection
Sirtuins are a family of enzymes involved in the regulation of gene expression, mitochondrial biogenesis and the cellular stress response. Critically, they are NAD+-dependent: they consume NAD+ as a substrate, so their activity is constrained by its availability.
This creates a direct mechanistic link between NAD+ levels and processes associated with cellular aging. If NAD+ falls, sirtuin activity is limited, and the regulatory functions that depend on it are affected. Much of the field's interest follows from this chain of reasoning.
The reasoning is sound but the chain is long. Demonstrating that each link holds under physiological conditions — rather than in isolated enzyme assays — is where much of the current research effort sits.
PARP enzymes and the DNA damage trade-off
Poly(ADP-ribose) polymerases also consume NAD+, and they do so in response to DNA damage. This sets up a resource competition: accumulated DNA damage drives PARP activity, which depletes NAD+, which in turn constrains the sirtuins that support mitochondrial function.
Researchers have framed this as one plausible route by which damage accumulation translates into functional metabolic decline, rather than the two being merely correlated with age.
The salvage pathway
Cells do not synthesise most of their NAD+ from scratch. They recycle it through the salvage pathway, converting nicotinamide back into NAD+ via intermediates including nicotinamide mononucleotide. This is why precursor compounds feature so heavily in the research literature — the pathway offers an obvious point of intervention.
The decline observed with age appears to involve both reduced salvage capacity and increased consumption, though the relative contribution of each is still debated.
What remains unresolved
That NAD+ declines with age is well established across multiple species and tissue types. What is not established is the direction of causation, or whether restoring levels restores function.
Preclinical work in aged animals has reported improvements in various metabolic markers following intervention. Translating that into a claim about human aging requires several inferential steps that the current evidence does not yet support. Research framing should reflect that gap honestly.
For laboratory research use only. This article summarises published research for scientific reference. It is not guidance for human or veterinary use, and nothing here describes a treatment for any condition. NexPep compounds are supplied strictly for laboratory research.